SERHA Spent $25.5 Billion on Procurement Without Consistently Demonstrating Value for Money, Auditor General Finds

The Auditor General of Jamaica has found that the South East Regional Health Authority — responsible for hospitals and health centres serving nearly half of the country’s population — failed to consistently demonstrate that it secured value for money from $25.5 billion in procurement spending over six years. The audit, covering 2011-12 to 2016-17, reveals structural weaknesses in planning that left one of the government’s most critical public health bodies unable to account properly for how it spent public funds on goods and services. For hundreds of thousands of Jamaicans who depend on SERHA facilities in Kingston, St. Andrew, St. Catherine, and St. Thomas, the findings raise serious questions about whether the authority’s limited resources were deployed to maximum effect.

When Jamaicans visit a public hospital or health centre in Kingston, St. Andrew, St. Catherine, or St. Thomas, they are placing trust not only in the doctors and nurses who treat them, but in the administrative systems that put supplies, medicines, and equipment in those facilities in the first place. A performance audit released by the Auditor General of Jamaica in May 2017 raises serious doubts about whether those systems were functioning as they should — and the scale of the concern is significant.

The South East Regional Health Authority, known as SERHA, is the largest of Jamaica’s four regional health authorities. It oversees nine hospitals and 91 health centres across four parishes that together account for approximately 47 per cent of the entire national population. That makes SERHA not merely a large public institution, but arguably the single most consequential health delivery body in the country. Over the six-year period examined by the audit — running from 2011-12 through to 2016-17 — Parliament allocated $87.6 billion to the authority. Of that total, $25.5 billion, representing 29 per cent of all funds received, was directed toward the purchase of goods and services, making procurement the second-largest expenditure category after salaries and wages.

The Auditor General’s conclusion, after examining how those billions were spent, was blunt: while SERHA broadly followed established procurement procedures, it did not consistently demonstrate that it had made genuine efforts to secure value for money. In other words, the authority may have ticked the procedural boxes without ensuring that taxpayers were actually getting the most from each dollar spent.

That distinction — between compliance and value — matters enormously in a public health context. Compliance means following the rules: issuing tenders, receiving bids, awarding contracts through the proper channels. Value for money means something more demanding. It means buying the right things, in the right quantities, at the right time, and at the best achievable price. The Auditor General found that SERHA’s procurement practices, however procedurally sound, could not consistently demonstrate they achieved the latter.

The root of the problem, according to the audit, lay at the very beginning of the procurement cycle: needs assessment. Before any organisation can plan what to buy, it must have a clear, evidence-based understanding of what it actually needs. At SERHA, that foundational step was found to be inadequate. The assessment of needs lacked the rigour necessary to inform strategic decision-making. There were no defined strategies for the allocation of resources — no framework that would allow management to weigh competing priorities across a sprawling network of hospitals and health centres and direct limited funds where they would do the most good.

The consequences of that gap cascaded through the system. Without a sound needs assessment at the base, SERHA’s ability to develop credible annual procurement plans was directly undermined. Annual procurement planning is not a bureaucratic formality — it is the mechanism through which an organisation forecasts what it will require, schedules competitive tendering to capture the best prices, avoids emergency purchases that typically cost more, and aligns spending with budget realities. When the foundation is weak, the planning built upon it is weak too.

This matters even more when viewed against SERHA’s fiscal position during the audit period. In addition to its Parliamentary allocation, the authority received $1.4 billion from the Culture, Health, Arts, Sports and Education Fund and the National Health Fund. Yet despite those supplementary inflows, SERHA faced a cumulative budget shortfall of $31 billion over the six years under review. The authority was not operating from a position of abundance. It was managing persistent resource constraints while simultaneously being expected to deliver healthcare to nearly half the country. In that environment, every dollar of procurement spending that fails to deliver value for money is a dollar that could have paid for medicines, supplies, or equipment that patients needed and did not receive.

For ordinary Jamaicans, the implications of the audit findings are not abstract. Procurement failures in a health authority are felt in concrete, human terms: shortages of surgical supplies, delays in the availability of diagnostic equipment, inconsistency in the stocking of essential medicines, and the quiet erosion of service quality that patients experience but may not connect to administrative dysfunction. The residents of Kingston who attend public hospitals, the rural communities in St. Thomas who rely on health centres as their primary point of care, and the families across St. Catherine who cannot afford private healthcare are all directly affected when SERHA’s procurement system does not perform as it should.

The audit’s findings are also relevant beyond the health sector. Jamaica’s public procurement framework exists precisely to protect taxpayers from waste, inefficiency, and the misuse of public funds. When an institution the size of SERHA — spending $25.5 billion over six years on goods and services alone — cannot demonstrate consistent value for money, it signals a systemic challenge that extends to governance and public financial management more broadly. The question of whether government institutions are getting value from what they buy is one that affects roads, schools, water infrastructure, and every other service that the state provides.

What the Auditor General identified at SERHA was not corruption or outright mismanagement, but something in some ways more difficult to address: a structural weakness in the planning and strategic thinking that underpins the entire procurement function. Procurement that is reactive rather than strategic — responding to immediate shortages rather than anticipating needs — is by definition more expensive and less effective. Emergency purchases bypass competitive tendering. Bulk discounts are missed. Suppliers gain leverage that should belong to the buyer. The authority, in effect, was repeatedly negotiating from a position of weakness rather than strength.

The Auditor General directed recommendations at both SERHA and its parent body, the Ministry of Health, recognising that addressing the weaknesses would require action at both the institutional and policy levels. The core thrust of those recommendations was the need to strengthen needs assessment processes — to make them evidence-based, structured, and forward-looking — and to establish defined strategies for the allocation of resources that would give annual procurement planning the credible foundation it had been lacking.

The Ministry of Health, as the body responsible for setting policy and providing oversight to SERHA and the other regional health authorities, was identified as a key part of the solution. The systemic nature of the weaknesses found — poor needs assessment, absent resource allocation strategies, impaired annual planning — suggests that the fixes required were not limited to adjustments at the operational level within SERHA alone. They pointed toward the need for stronger guidance, monitoring, and accountability from the ministry itself.

The period covered by the audit, 2011-12 to 2016-17, was one in which the Jamaican government was navigating a demanding economic adjustment programme. Fiscal restraint was a national priority, and public institutions across the board were under pressure to do more with less. That context makes the absence of value-for-money discipline in SERHA’s procurement not merely a health sector concern, but a reflection of a broader challenge: the difficulty of maintaining rigorous public financial management when institutions are stretched, budgets are cut, and the temptation to focus on day-to-day crisis management crowds out strategic planning.

It is precisely in those conditions that strong procurement practices matter most. When resources are scarce, the difference between strategic procurement and reactive procurement is not marginal — it is material. An authority managing a $31 billion deficit over six years cannot afford to leave efficiency gains on the table through inadequate needs assessment and the absence of resource allocation frameworks.

The audit does not suggest that the goods and services SERHA purchased were unnecessary or that the authority acted in bad faith. What it finds is that the system through which those purchases were made was not structured to extract maximum value from the funds available. That is a finding with direct, practical consequences for the quality and availability of public healthcare across the most densely populated region of Jamaica.

The Auditor General’s report, published in May 2017, was directed to both SERHA and the Ministry of Health with a clear expectation of action. Whether the recommendations were implemented in full, and whether the improvements in needs assessment and resource allocation planning that were called for have taken root, remains a question of ongoing public interest. What the audit establishes, with the authority of an independent constitutional office, is that at the time of review, the systems governing $25.5 billion in health procurement spending were not meeting the standard that Jamaican taxpayers and patients had every right to expect.

For a country investing heavily in healthcare delivery and working to close persistent gaps in access and quality, the audit’s findings point toward an uncomfortable truth: good intentions and procedural compliance are not sufficient. Value for money demands planning, strategy, and the discipline to assess needs honestly before money is spent. Until those foundations are in place and consistently maintained, the risk of waste in public procurement — even in the absence of any deliberate wrongdoing — remains a structural vulnerability in Jamaica’s health system.

Jamaica Accountability Watch is an independent editorial series by Jamaica Homes News examining what government audit reports reveal about the management of public money. Source: Auditor General’s Department of Jamaica.

Follow Jamaica Homes on Youtube @jamaicahomes and Instagram @jamaica_homes and on Facebook @jamaicahomes Send us a message or email us at onlinefeedback@jamaica-homes.com or editor@jamaica-homes.com